Breakthrough Medical Device Gives Hope for Blindness-Related Diseases

The ScyFIX 700 therapy uses microcurrent neuromodulation that generates a tiny current of electricity to stimulate the body’s own healing capabilities. This is the first-ever device therapy approval for Retinitis Pigmentosa (RP), a degenerative disease where peripheral vision is lost that can lead to total blindness. Additional approvals for the treatment of other blindness-related diseases are expected soon, including AMD.

The ScyFIX 700 works by administering a tiny current of electricity that stimulates the body’s own healing capabilities. ScyFIX, based in Minneapolis, Minn., has developed the technology over the past seven years. A video describing the ScyFIX 700 system is available at http://www.onemedplace.com/database/list/cid/9896/.  More information is also available on www.scyfix.org.  

SkyFIX 700

SkyFIX 700

 http://www.businesswire.com/portal/site/google/?ndmViewId=news_view&newsId=20090505005523&newsLang=en

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: